FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma.
Saved in:
| Title: | FOXM1 inhibitor, RCM‑1, enhances venetoclax mediated apoptosis through downregulation of ATP2B4 in rhabdomyosarcoma. |
|---|---|
| Authors: | Merjaneh N; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA., Lan YW; Phoenix Children's Research Institute, The University of Arizona College of Medicine‑Phoenix, Phoenix, AZ 85004, USA., Deng Z; Phoenix Children's Research Institute, The University of Arizona College of Medicine‑Phoenix, Phoenix, AZ 85004, USA., Donovan J; Division of Neonatology and Pulmonary Biology, Perinatal Institute, Cincinnati Children's Research Foundation, Cincinnati, OH 45229, USA., Wang G; Division of Neonatology and Pulmonary Biology, Perinatal Institute, Cincinnati Children's Research Foundation, Cincinnati, OH 45229, USA., Do J; Phoenix Children's Research Institute, The University of Arizona College of Medicine‑Phoenix, Phoenix, AZ 85004, USA., Juan T; Phoenix Children's Research Institute, The University of Arizona College of Medicine‑Phoenix, Phoenix, AZ 85004, USA., Xia X; Phoenix Children's Research Institute, The University of Arizona College of Medicine‑Phoenix, Phoenix, AZ 85004, USA., Kalinichenko VV; Phoenix Children's Research Institute, The University of Arizona College of Medicine‑Phoenix, Phoenix, AZ 85004, USA., Kalin TV; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA. |
| Source: | International journal of oncology [Int J Oncol] 2026 May; Vol. 68 (5). Date of Electronic Publication: 2026 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
